Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||ER1741 / 2||- / -|
Administered by: Other Purchased by: ??
Symptoms: Death, Myelodysplastic syndrome
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Other Medications: AZACITIDINE; ERYTHROPOIETIN; OMEPRAZOLE; SOLIFENACIN; TRANEXAMIC ACID
Preexisting Conditions: Medical History/Concurrent Conditions: Myelodysplasia; Neoplasm (Recently had treatment for cancer, leukaemia or lymphoma (radiotherapy or chemotherapy)); Platelet transfusion
Diagnostic Lab Data:
CDC 'Split Type': GBPFIZER INC2021258425
Write-up: myelodysplasia; Death; This is a spontaneous report from a contactable physician. This is a report received from the Regulatory Authority. Regulatory authority report number GB-MHRA-WEBCOVID-202103081208347660, Safety Report Unique Identifier GB-MHRA-ADR 24899259. A 74-year-old male patient received his second dose of BNT162B2 (PFIZER-BIONTECH, COVID-19 MRNA VACCINE; Lot number: ER1741), via an unspecified route of administration on 06Mar2021 for COVID-19 immunisation. Medical history included neoplasm (Recently had treatment for cancer, leukaemia or lymphoma (radiotherapy or chemotherapy)) from an unknown date and unknown if ongoing, platelet transfusion from 20Feb2021 to an unknown date, High grade myelodysplasia from an unknown date and unknown if ongoing. It was reported that the patient has not had symptoms associated with COVID-19, was not enrolled in clinical trial, and the patient did not have COVID-19 test. Concomitant medications included azacitidine, erythropoietin, omeprazole, solifenacin and tranexamic acid. The patient experienced myelodysplasia on an unspecified date and was found dead at home on 07Mar2021 of unknown cause. The patient was unresponsive and was referred to coroner. It was not reported if an autopsy was performed. The outcome of medically significant event of myelodysplasia was unknown. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Unknown cause of death
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166